Vaccine Technologies Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: VF6A47BF7285EN
Market Monitor Global

Abstracts

Vaccine technologies have been in development since the initial use of killed viral and killed bacterial vaccines.

This report contains market size and forecasts of Vaccine Technologies in Global, including the following market information:

Global Vaccine Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Vaccine Technologies market was valued at 46890 million in 2021 and is projected to reach US$ 67190 million by 2028, at a CAGR of 5.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Infection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vaccine Technologies include Abbott, Pfizer, Bayer, GE Healthcare, Glaxosmithkline, Johnson and Johnson and Thermo Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccine Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaccine Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Vaccine Technologies Market Segment Percentages, by Type, 2021 (%)

• Infection
• Allergy
• Cancer

Global Vaccine Technologies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Vaccine Technologies Market Segment Percentages, by Application, 2021 (%)

• Humans
• Animals

Global Vaccine Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Vaccine Technologies Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaccine Technologies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Vaccine Technologies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Pfizer
• Bayer
• GE Healthcare
• Glaxosmithkline
• Johnson and Johnson
• Thermo Fisher Scientific

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vaccine Technologies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vaccine Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VACCINE TECHNOLOGIES OVERALL MARKET SIZE

2.1 Global Vaccine Technologies Market Size: 2021 VS 2028
2.2 Global Vaccine Technologies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vaccine Technologies Players in Global Market
3.2 Top Global Vaccine Technologies Companies Ranked by Revenue
3.3 Global Vaccine Technologies Revenue by Companies
3.4 Top 3 and Top 5 Vaccine Technologies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vaccine Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaccine Technologies Players in Global Market
  3.6.1 List of Global Tier 1 Vaccine Technologies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vaccine Technologies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Vaccine Technologies Market Size Markets, 2021 & 2028
  4.1.2 Infection
  4.1.3 Allergy
  4.1.4 Cancer
4.2 By Type - Global Vaccine Technologies Revenue & Forecasts
  4.2.1 By Type - Global Vaccine Technologies Revenue, 2017-2022
  4.2.2 By Type - Global Vaccine Technologies Revenue, 2023-2028
  4.2.3 By Type - Global Vaccine Technologies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vaccine Technologies Market Size, 2021 & 2028
  5.1.2 Humans
  5.1.3 Animals
5.2 By Application - Global Vaccine Technologies Revenue & Forecasts
  5.2.1 By Application - Global Vaccine Technologies Revenue, 2017-2022
  5.2.2 By Application - Global Vaccine Technologies Revenue, 2023-2028
  5.2.3 By Application - Global Vaccine Technologies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vaccine Technologies Market Size, 2021 & 2028
6.2 By Region - Global Vaccine Technologies Revenue & Forecasts
  6.2.1 By Region - Global Vaccine Technologies Revenue, 2017-2022
  6.2.2 By Region - Global Vaccine Technologies Revenue, 2023-2028
  6.2.3 By Region - Global Vaccine Technologies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Vaccine Technologies Revenue, 2017-2028
  6.3.2 US Vaccine Technologies Market Size, 2017-2028
  6.3.3 Canada Vaccine Technologies Market Size, 2017-2028
  6.3.4 Mexico Vaccine Technologies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Vaccine Technologies Revenue, 2017-2028
  6.4.2 Germany Vaccine Technologies Market Size, 2017-2028
  6.4.3 France Vaccine Technologies Market Size, 2017-2028
  6.4.4 U.K. Vaccine Technologies Market Size, 2017-2028
  6.4.5 Italy Vaccine Technologies Market Size, 2017-2028
  6.4.6 Russia Vaccine Technologies Market Size, 2017-2028
  6.4.7 Nordic Countries Vaccine Technologies Market Size, 2017-2028
  6.4.8 Benelux Vaccine Technologies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Vaccine Technologies Revenue, 2017-2028
  6.5.2 China Vaccine Technologies Market Size, 2017-2028
  6.5.3 Japan Vaccine Technologies Market Size, 2017-2028
  6.5.4 South Korea Vaccine Technologies Market Size, 2017-2028
  6.5.5 Southeast Asia Vaccine Technologies Market Size, 2017-2028
  6.5.6 India Vaccine Technologies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Vaccine Technologies Revenue, 2017-2028
  6.6.2 Brazil Vaccine Technologies Market Size, 2017-2028
  6.6.3 Argentina Vaccine Technologies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vaccine Technologies Revenue, 2017-2028
  6.7.2 Turkey Vaccine Technologies Market Size, 2017-2028
  6.7.3 Israel Vaccine Technologies Market Size, 2017-2028
  6.7.4 Saudi Arabia Vaccine Technologies Market Size, 2017-2028
  6.7.5 UAE Vaccine Technologies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Vaccine Technologies Major Product Offerings
  7.1.4 Abbott Vaccine Technologies Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Vaccine Technologies Major Product Offerings
  7.2.4 Pfizer Vaccine Technologies Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Vaccine Technologies Major Product Offerings
  7.3.4 Bayer Vaccine Technologies Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 GE Healthcare
  7.4.1 GE Healthcare Corporate Summary
  7.4.2 GE Healthcare Business Overview
  7.4.3 GE Healthcare Vaccine Technologies Major Product Offerings
  7.4.4 GE Healthcare Vaccine Technologies Revenue in Global Market (2017-2022)
  7.4.5 GE Healthcare Key News
7.5 Glaxosmithkline
  7.5.1 Glaxosmithkline Corporate Summary
  7.5.2 Glaxosmithkline Business Overview
  7.5.3 Glaxosmithkline Vaccine Technologies Major Product Offerings
  7.5.4 Glaxosmithkline Vaccine Technologies Revenue in Global Market (2017-2022)
  7.5.5 Glaxosmithkline Key News
7.6 Johnson and Johnson
  7.6.1 Johnson and Johnson Corporate Summary
  7.6.2 Johnson and Johnson Business Overview
  7.6.3 Johnson and Johnson Vaccine Technologies Major Product Offerings
  7.6.4 Johnson and Johnson Vaccine Technologies Revenue in Global Market (2017-2022)
  7.6.5 Johnson and Johnson Key News
7.7 Thermo Fisher Scientific
  7.7.1 Thermo Fisher Scientific Corporate Summary
  7.7.2 Thermo Fisher Scientific Business Overview
  7.7.3 Thermo Fisher Scientific Vaccine Technologies Major Product Offerings
  7.7.4 Thermo Fisher Scientific Vaccine Technologies Revenue in Global Market (2017-2022)
  7.7.5 Thermo Fisher Scientific Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Vaccine Technologies Market Opportunities & Trends in Global Market
Table 2. Vaccine Technologies Market Drivers in Global Market
Table 3. Vaccine Technologies Market Restraints in Global Market
Table 4. Key Players of Vaccine Technologies in Global Market
Table 5. Top Vaccine Technologies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vaccine Technologies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vaccine Technologies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vaccine Technologies Product Type
Table 9. List of Global Tier 1 Vaccine Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Technologies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vaccine Technologies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vaccine Technologies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vaccine Technologies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Vaccine Technologies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vaccine Technologies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vaccine Technologies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Vaccine Technologies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vaccine Technologies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vaccine Technologies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vaccine Technologies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vaccine Technologies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vaccine Technologies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vaccine Technologies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vaccine Technologies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vaccine Technologies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vaccine Technologies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vaccine Technologies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vaccine Technologies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vaccine Technologies Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Vaccine Technologies Product Offerings
Table 32. Abbott Vaccine Technologies Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Vaccine Technologies Product Offerings
Table 35. Pfizer Vaccine Technologies Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Vaccine Technologies Product Offerings
Table 38. Bayer Vaccine Technologies Revenue (US$, Mn), (2017-2022)
Table 39. GE Healthcare Corporate Summary
Table 40. GE Healthcare Vaccine Technologies Product Offerings
Table 41. GE Healthcare Vaccine Technologies Revenue (US$, Mn), (2017-2022)
Table 42. Glaxosmithkline Corporate Summary
Table 43. Glaxosmithkline Vaccine Technologies Product Offerings
Table 44. Glaxosmithkline Vaccine Technologies Revenue (US$, Mn), (2017-2022)
Table 45. Johnson and Johnson Corporate Summary
Table 46. Johnson and Johnson Vaccine Technologies Product Offerings
Table 47. Johnson and Johnson Vaccine Technologies Revenue (US$, Mn), (2017-2022)
Table 48. Thermo Fisher Scientific Corporate Summary
Table 49. Thermo Fisher Scientific Vaccine Technologies Product Offerings
Table 50. Thermo Fisher Scientific Vaccine Technologies Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Vaccine Technologies Segment by Type in 2021
Figure 2. Vaccine Technologies Segment by Application in 2021
Figure 3. Global Vaccine Technologies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vaccine Technologies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vaccine Technologies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaccine Technologies Revenue in 2021
Figure 8. By Type - Global Vaccine Technologies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vaccine Technologies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vaccine Technologies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vaccine Technologies Revenue Market Share, 2017-2028
Figure 12. US Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vaccine Technologies Revenue Market Share, 2017-2028
Figure 16. Germany Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 17. France Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vaccine Technologies Revenue Market Share, 2017-2028
Figure 24. China Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 28. India Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vaccine Technologies Revenue Market Share, 2017-2028
Figure 30. Brazil Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vaccine Technologies Revenue Market Share, 2017-2028
Figure 33. Turkey Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vaccine Technologies Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Vaccine Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Vaccine Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Vaccine Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GE Healthcare Vaccine Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glaxosmithkline Vaccine Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson and Johnson Vaccine Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Thermo Fisher Scientific Vaccine Technologies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)